Literature DB >> 12775979

Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.

Rita E Fisler1, Marcela Saeb, Marilyn G Liang, Renee M Howard, Phillip H McKee.   

Abstract

Bullous pemphigoid (BP) is an acquired bullous disorder that predominantly affects the elderly. It is rare in children but when it occurs, there is considerable clinical and histologic overlap with other acquired or congenital blistering disorders. A definitive diagnosis of childhood BP requires direct immunofluorescence and, in some cases, characterization of the target antigen. Three cases of childhood BP are presented, with their histologic and immunofluorescence findings. The first was a 5-month-old male infant who presented with erythema and bullae of the palms and soles and was found to have linear deposition of IgG and C3 along the dermoepidermal junction on direct immunofluorescence (DIF). Histopathologic examination revealed a subepidermal blister containing eosinophils. Type IV collagen was demonstrated along the floor of the blister cavity by a direct immunoperoxidase technique. The second case was an 8-month-old female infant who presented with a blistering eruption of her palms and soles that then became widespread. Direct immunofluorescence showed linear IgG and C3 at the dermoepidermal junction, with laminin deposition at the base of the blister. The third case was a 7-year-old female with bullae and erosions on the vulva and vaginal mucosa. A subepidermal blister was seen on microscopic examination whereas immunofluorescence demonstrated linear IgG and C3 deposition at the basement membrane zone (BMZ). A literature review uncovered 50 cases of childhood BP confirmed by direct or indirect immunofluorescence, or both, and often with evidence of autoantibodies against either the 180 kD or the 230 kD human bullous pemphigoid antigens (BP180 or BP230). This review was used to delineate characteristics of childhood BP, including the newly proposed subtypes: infantile BP and childhood localized vulval BP. Infantile BP presents within the first year of life and is characterized by BP-like lesions on erythematous or normal acral skin. Localized vulval BP is a self-limited, nonscarring BP-like process that involves only the vulva. Both subtypes are normally self-limited and respond well to either topical or systemic steroids, if treatment is initiated before the disease becomes widespread.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12775979     DOI: 10.1097/00000372-200306000-00001

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  12 in total

1.  Bullous pemphigoid in infant post vaccination: Myth or reality?

Authors:  Iria Neri; Antonella Greco; Andrea Bassi; Jacinto Orgaz-Molina; Riccardo Balestri; Teresa Oranges; Annalisa Patrizi; Maurizio de Martino
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

Review 2.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

3.  [Pediatric linear IgA/IgG dermatosis].

Authors:  Orsolya N Horváth; Tanja von Braunmühl; Miklós Sárdy
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

4.  Non infective bullous lesions: a diagnostic challenge in a minimally equipped centre- based solely on microscopic findings.

Authors:  Rashi Garg; Kaushal Bhojani
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

Review 5.  Cutaneous drug reactions in children: an update.

Authors:  Kara Heelan; Neil H Shear
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

6.  A Systematic Review of Drug-Induced Pemphigoid.

Authors:  Matthew J Verheyden; Asli Bilgic; Dédée F Murrell
Journal:  Acta Derm Venereol       Date:  2020-08-17       Impact factor: 3.875

7.  Bullous Pemphigoid in Three Paediatric Patients in Finland.

Authors:  Anna Pankakoski; Jaana Panelius; Alexander Salava; Nicolas Kluger
Journal:  Acta Derm Venereol       Date:  2020-03-18       Impact factor: 3.875

8.  Three case reports of post immunization and post viral Bullous Pemphigoid: looking for the right trigger.

Authors:  Luca Baroero; Paola Coppo; Laura Bertolino; Stefano Maccario; Francesco Savino
Journal:  BMC Pediatr       Date:  2017-02-23       Impact factor: 2.125

Review 9.  Bullous pemphigoid.

Authors:  Denise Miyamoto; Claudia Giuli Santi; Valéria Aoki; Celina Wakisaka Maruta
Journal:  An Bras Dermatol       Date:  2019-05-09       Impact factor: 1.896

10.  Bullous pemphigoid in infants: characteristics, diagnosis and treatment.

Authors:  Agnes Schwieger-Briel; Cornelia Moellmann; Birgit Mattulat; Franziska Schauer; Dimitra Kiritsi; Enno Schmidt; Cassian Sitaru; Hagen Ott; Johannes S Kern
Journal:  Orphanet J Rare Dis       Date:  2014-12-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.